Study Protocol of Cardiac Rehabilitation for Acute Myocardial Infarction From the JROAD/JROAD-DPC Database　- JROAD-CR.

Autor:	Suematsu Y; Department of Cardiology, Fukuoka University Hospital Fukuoka Japan., Miura SI; Department of Cardiology, Fukuoka University School of Medicine Fukuoka Japan., Minei A; Department of Rehabilitation, University of the Ryukyu Hospital Okinawa Japan., Sumita Y; National Cerebral and Cardiovascular Center Osaka Japan., Kanaoka K; National Cerebral and Cardiovascular Center Osaka Japan., Nakai M; National Cerebral and Cardiovascular Center Osaka Japan., Arima H; Department of Preventive Medicine and Public Health, Fukuoka University Fukuoka Japan., Nakamura K; Department of Public Health and Hygiene, Graduate School of Medicine, University of the Ryukyus Okinawa Japan., Takura T; Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo Tokyo Japan., Shimada K; Senkawadori Clinic Tokyo Japan., Shiraishi H; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine Kyoto Japan., Fukuma N; Faculty of Rehabilitation and Care, Seijoh University Aichi Japan., Ohya Y; Department of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus Okinawa Japan., Makita S; Department of Cardiac Rehabilitation, Saitama International Medical Center, Saitama Medical University Saitama Japan.
Jazyk:	angličtina
Zdroj:	Circulation reports [Circ Rep] 2023 Jan 25; Vol. 5 (2), pp. 62-65. Date of Electronic Publication: 2023 Jan 25 (Print Publication: 2023).
DOI:	10.1253/circrep.CR-22-0121
Abstrakt:	Background: Although cardiac rehabilitation (CR) has been reported to be effective for improving the prognosis of acute myocardial infarction (AMI), more patients must participate in CR during admission and as outpatients. Factors contributing to, and countermeasures against, the low CR participation rate need to be identified. Here we describe the protocol for a study designed to evaluate the effectiveness and problems of CR for AMI from the Japanese Registry of All Cardiac and Vascular Diseases (JROAD) and the JROAD-Japanese Diagnosis Procedure Combination system (JROAD-DPC) database. Methods and Results: This is a multicenter retrospective cohort study that will use the JROAD/JROAD-DPC database to evaluate the effectiveness of CR for AMI (JROAD-CR). Five thousand patients with AMI who were admitted to hospitals registered in the JROAD database in 2014 will be investigated with regard to their baseline characteristics, AMI severity and treatment, examination results, history of CR, and prognosis up to 5 years. We will also investigate the presence, quantity, and quality of CR, and evaluate the effectiveness of CR with respect to cost, exercise tolerance, and prognosis during admission and follow-up. Conclusions: The JROAD-CR study will seek to reveal the effectiveness of CR for AMI in the era of early reperfusion therapy and shortened hospitalization. Competing Interests: S. Miura has received remuneration from Otsuka Pharmaceutical Co., Ltd., Takeda Pharm. Co. Ltd., Daiichi Sankyo Co. Ltd., Bayer Yakuhin Ltd., and Boehringer-Ingelheim; research funding from Takeda Pharm. Co. Ltd., Daiichi Sankyo Co. Ltd., Abbott Medical Japan LLC, Boehringer-Ingelheim, Bayer Yakuhin Ltd., Astellas Pharma Inc., Sumitomo Dainippon Pharma. Co., Medtronic, HeartFlow Japan GK, MSD KK, Novartis, Pfizer Japan Inc., and TEIJIN Pharma; and scholarship funds from OMRON Co., SOMPO Japan, and Boston Scientific, Y. Suematsu has received research funding from Uehara Memorial Foundation and Suzuken Memorial Foundation. S. Miura, T.T., and Y.O. are members of Circulation Reports’ Editorial Team. (Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu